Furosemide Tablets USP recall: CGMP Deviations
FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216…
Why was Furosemide Tablets USP recalled?
CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 559660P, 559661P, Exp 03/17
- Product
- FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216…
- Recalling firm
- Boehringer Ingelheim Roxane Inc
- Quantity
- 11,110 bottles
- Distribution
- Nationwide and Puerto Rico
- Recall date
- October 21, 2015
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)